In the molecular signature database (MSigDB), these five genes are involved with oncogenic signaling, e.g., androgen response (IRF2BP2), hypoxia (GPI, HMOX1), mTORC1 (GPI), mitotic checkpoint (KIF3C), and poor prognosis mutant drivers of prostate cancer, e.g., TP53 (HMOX1) and PTEN/AKT (EDARADD). This evidence concerns the gene TP53 and prostate cancer.